Neuromyelin is a biotechnology company focused on developing innovative therapies for neurological diseases. The company specializes in addressing conditions related to myelin repair and neuroprotection, leveraging advanced research in neuroscience and molecular biology. Neuromyelin aims to improve patient outcomes through its proprietary technologies and drug development pipelines, targeting disorders such as multiple sclerosis and other demyelinating diseases.